Last synced on 6 December 2024 at 11:05 pm

cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System

Page Type
Cleared 510(K)
PDF
FDA Hosted PDF
* The FDA doesn't provide PDFs for all submissions.
510(k) Number
K223591
510(k) Type
Dual Track
Applicant
Roche Molecular Systems, Inc.
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
7/27/2023
Days to Decision
238 days
Submission Type
Summary

cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System

Page Type
Cleared 510(K)
PDF
FDA Hosted PDF
* The FDA doesn't provide PDFs for all submissions.
510(k) Number
K223591
510(k) Type
Dual Track
Applicant
Roche Molecular Systems, Inc.
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
7/27/2023
Days to Decision
238 days
Submission Type
Summary